PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.40%
Revenue growth under 50% of 2127.T's 33.97%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
3.40%
Gross profit growth under 50% of 2127.T's 83.60%. Michael Burry would be concerned about a severe competitive disadvantage.
-2.91%
Negative EBIT growth while 2127.T is at 132.83%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
4.04%
Operating income growth under 50% of 2127.T's 128.15%. Michael Burry would be concerned about deeper cost or sales issues.
-15.54%
Negative net income growth while 2127.T stands at 120.64%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.54%
Negative EPS growth while 2127.T is at 120.63%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.54%
Negative diluted EPS growth while 2127.T is at 116.67%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share count expansion well above 2127.T's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.00%
Diluted share reduction more than 1.5x 2127.T's 1.83%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
59.57%
10Y revenue/share CAGR under 50% of 2127.T's 644.48%. Michael Burry would suspect a lasting competitive disadvantage.
57.04%
5Y revenue/share CAGR under 50% of 2127.T's 214.28%. Michael Burry would suspect a significant competitive gap or product weakness.
29.96%
3Y revenue/share CAGR under 50% of 2127.T's 75.92%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
86.45%
Below 50% of 2127.T's 769.43%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
86.04%
Below 50% of 2127.T's 248.15%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
9.43%
Below 50% of 2127.T's 76.00%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
130.07%
5Y equity/share CAGR at 75-90% of 2127.T's 154.87%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
62.57%
3Y equity/share CAGR similar to 2127.T's 62.39%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-39.20%
Firm’s AR is declining while 2127.T shows 48.13%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-3.35%
Inventory is declining while 2127.T stands at 3.16%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.06%
Positive asset growth while 2127.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.14%
1.25-1.5x 2127.T's 2.57%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-41.08%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
96.39%
SG&A growth well above 2127.T's 10.80%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.